2018-2019 Microbiology Products US Catalog

Total Page:16

File Type:pdf, Size:1020Kb

2018-2019 Microbiology Products US Catalog 2018-2019 Microbiology Products US Catalog Clinical • Food & Beverage • Pharmaceutical • Environmental • Veterinary Contents General Information 1 Quality Control 178 BactiDisk and Culti-Loop ���������������������������������������������������������� 180 Product Usage Guide 4 Culti-Loop Sets ������������������������������������������������������������������������ 200 CFUrine Kit Quality Control ������������������������������������������������������� 205 Quanti-Cult ������������������������������������������������������������������������������� 206 Prepared Culture Media 14 Quanti-Cult Plus ����������������������������������������������������������������������� 206 Monoplates, Tubes, Bottles �������������������������������������������������������� 18 Waterbugs �������������������������������������������������������������������������������� 207 Biplates �������������������������������������������������������������������������������������� 70 WKITS �������������������������������������������������������������������������������������� 208 Triplates �������������������������������������������������������������������������������������� 71 Spore Strips ����������������������������������������������������������������������������� 208 Quadplates ��������������������������������������������������������������������������������� 72 Molecular Diagnostic Test Controls ������������������������������������������� 208 Contact and Settling Plates �������������������������������������������������������� 73 QC-Slide Stain Controls ������������������������������������������������������������ 208 Dilution Bottles ��������������������������������������������������������������������������� 76 Reagent QC Kit ������������������������������������������������������������������������ 209 Dehydrated Culture Media 78 Reagents and Stains 210 Dry-Bags™ (including instruments and accessories) ������������������� 80 Bactidrop Reagents ������������������������������������������������������������������ 212 FitBags™ ����������������������������������������������������������������������������������� 81 General Reagents ��������������������������������������������������������������������� 213 QuickBags™ ������������������������������������������������������������������������������ 81 BactiDrop Stains ����������������������������������������������������������������������� 216 Remel Dehydrated Culture Media ����������������������������������������������� 82 General Stains �������������������������������������������������������������������������� 217 Remel Components, Supplements, Additives ����������������������������� 91 Gram Stains ����������������������������������������������������������������������������� 219 Remel Animal Blood ������������������������������������������������������������������� 93 Fixatives ����������������������������������������������������������������������������������� 220 Oxoid Dehydrated Culture Media ������������������������������������������������ 93 QC-Slide Stain Controls ������������������������������������������������������������ 221 Oxoid Veggietones: Animal-free Peptones �������������������������������� 110 Oxoid Components, Supplements, Additives ���������������������������� 111 Identification and Susceptibility Tests 222 RapID ��������������������������������������������������������������������������������������� 224 Collection and Transport 120 Antimicrobial Susceptibility Disks ���������������������������������������������� 225 Fecal Transport ������������������������������������������������������������������������ 122 Antimicrobial Susceptibility Disk Dispensers & Supplies ������������ 227 Fecal Concentration ����������������������������������������������������������������� 123 Automated Instrumentation ������������������������������������������������������ 228 Fixatives ����������������������������������������������������������������������������������� 123 Sensititre Supplies �������������������������������������������������������������������� 229 General Transport ��������������������������������������������������������������������� 124 BactiSwab �������������������������������������������������������������������������������� 125 Blood Culture 232 Microtest ���������������������������������������������������������������������������������� 126 Automated Instrumentation ����������������������������������������������������� 234 ESwabs ������������������������������������������������������������������������������������ 127 Manual Blood Culture ��������������������������������������������������������������� 236 FecalSwab ������������������������������������������������������������������������������� 127 SnotBuster ������������������������������������������������������������������������������� 127 Food Safety & Quality by Organism 238 Pre-Analytical Automation 128 Aerobic Colony Counts / Plate Counts �������������������������������������� 240 Bacillus ������������������������������������������������������������������������������������� 240 Copan WASP™DT Instrumentation ������������������������������������������ 130 Campylobacter ������������������������������������������������������������������������� 242 Cronobacter sakazakii �������������������������������������������������������������� 246 Diagnostic Tests 132 Enterobacteriaceae and Coliforms �������������������������������������������� 247 Diagnostic Tests Quick Reference ��������������������������������������������� 134 Escherichia coli ������������������������������������������������������������������������� 251 Remel Agglutinating Sera ���������������������������������������������������������� 138 Listeria �������������������������������������������������������������������������������������� 256 General Diagnostic Tests ���������������������������������������������������������� 140 Pseudomonas �������������������������������������������������������������������������� 260 Salmonella �������������������������������������������������������������������������������� 261 Shigella ������������������������������������������������������������������������������������� 266 Laboratory Supplies 166 Staphylococcus ������������������������������������������������������������������������ 268 Autoclave Bags & Deodorant ���������������������������������������������������� 168 Vibrio ���������������������������������������������������������������������������������������� 270 Dilution Bottles ������������������������������������������������������������������������� 168 Yeasts and Molds ��������������������������������������������������������������������� 271 Environmental Systems ����������������������������������������������������������� 168 Dry-Bags ���������������������������������������������������������������������������������� 275 Mitsubishi Consumables ����������������������������������������������������������� 168 Mitsubishi Hardware ����������������������������������������������������������������� 169 Oxoid 3�5L System ������������������������������������������������������������������� 170 Molecular Food Safety & Quality 278 Oxoid 2�5L System ������������������������������������������������������������������� 171 Sample Prep for molecular and non-molecular workflows �������� 280 Oxoid Compact System ����������������������������������������������������������� 171 Food molecular detection and quantification ����������������������������� 281 Anaerobic Indicators ����������������������������������������������������������������� 172 SureTect System ���������������������������������������������������������������������� 283 Equipment �������������������������������������������������������������������������������� 172 Equivalence Turbidity Standards ����������������������������������������������� 172 Instrumentation ������������������������������������������������������������������������� 173 Petri Dishes, Racks, Seals �������������������������������������������������������� 175 Sample Collection ��������������������������������������������������������������������� 175 Skin Prep ���������������������������������������������������������������������������������� 175 Additional Products ������������������������������������������������������������������ 176 Thermo Scientific General Information Agawam, MA Milwaukee, WI Nazareth, PA Cleveland, OH Fremont, CA Thermo Fisher Scientific Hanover Park, IL Remel Inc� Lenexa, KS Florence, KY P�O� Box 14428 12076 Santa Fe Trail Drive Lenexa, KS 66215-3594 Dallas, TX Atlanta, GA Toll-Free 800-255-6730 Norcross, GA Customer Service Fax 800-447-5761 CSemail@thermofisher�com www�thermofisher�com/microbiology About Us Thermo Fisher Scientific Inc� is the world leader in serving science� products, we strive to be your trusted partner for every step of Our mission is to enable our customers to make the world the microbiology workflow� For more information, please visit healthier, cleaner and safer� We help our customers accelerate life www�thermofisher�com/microbiology� sciences research, solve complex analytical challenges, improve patient diagnostics and increase laboratory productivity� Our Excellent Service four premier brands – Thermo Scientific™, Life Technologies™, An extensive product portfolio of superior performing products is Fisher Scientific™ and Unity Lab Services™ – offer an unmatched complemented by a team of experts dedicated to providing the combination of innovative technologies, purchasing convenience highest levels of technical support and customer service possible� and comprehensive support� Our Technical Service department is available
Recommended publications
  • Dehydrated Culture Media Description Packaging Ref
    Product Catalogue 2016 © Liofilchem® s.r.l. Clinical and Industrial Microbiology Est. 1983 Dehydrated Culture Media Description Packaging Ref. A1 Medium APHA 500 g 610105 Basal liquid medium for fecal coliforms detection in water and food. 100 g 620105 TRITON X 100 supplement 5x5 mL 80046 Acetamide Agar 500 g 610312 Medium for differentiation of nonfermentative, Gram-negative bacteria, especially Pseudomonas aeruginosa, on the basis of acetamide utilization. Acetamide Broth 500 g 610313 Broth for the differentiation of nonfermentative, Gram-negative bacteria, especially Pseudomonas aeruginosa, on the basis of acetamide utilization. Aeromonas Agar Base 500 g 610048 Basal medium for selective isolation of Aeromonas spp. 100 g 620048 Ampicillin supplement 10 vials 81001 Alkaline Peptone Water APHA 500 g 610098 Liquid enrichment medium for Vibrio spp. isolation. 100 g 620098 Amies Transport Medium (with charcoal) 500 g 610152 Semi-solid medium for transport of clinical, environmental specimens and of 100 g 620152 microorganisms. 5 kg 6101525 Amies Transport Medium (w/o charcoal) 500 g 610191 Semi-solid medium for transport of clinical, environmental specimens and of 100 g 620191 microorganisms. 5 kg 6101915 Anaerobic Agar (Brewer) 500 g 610320 Medium for cultivating anaerobic microorganisms. Andrade Lactose Peptone Water 500 g 610118 Liquid medium for coliforms detection with andrade's indicator. 100 g 620118 Andrade Peptone Water 500 g 610119 Liquid enrichment medium with andrade's indicator. 100 g 620119 Antibiotic Agar No.1 E.P. 500 g 610314 Surface medium for the antibiotic assay by Agar-diffusion method. Antibiotic Broth No.3 U.S.P. 500 g 610316 Broth for turbidimetric assay of antibiotics.
    [Show full text]
  • CAMP Tests (Standard and Rapid) and Reverse CAMP Test
    M.V.Sc. (Veterinary Microbiology), Monsoon semester Date 31.12.2020 VMC- 602 (Bacteriology II), Unit III, Practical class CAMP Tests (Standard and Rapid) and Reverse CAMP test Dr. Savita Kumari Assistant Professor-cum-Jr. Scientist Department of Veterinary Microbiology Bihar Veterinary College, BASU, Patna CAMP factor S. agalactiae contains the CAMP factor, only beta-hemolytic Streptococcus secretes Pore -forming toxin first identified in this bacterium CAMP reaction is based on the co -hemolytic activity of the CAMP factor Commonly used to identify S. agalactiae Closely related proteins present also in other Gram - positive pathogens cfb gene encodes CAMP factor CAMP test CAMP reaction- consists in a zone of strong hemolysis that is observed when S. agalactiae is streaked next to Staphylococcus aureus on blood agar S. aureus secretes sphingomyelinase Sheep red blood cells - rich in sphingomyelin, and upon exposure to sphingomyelinase become greatly sensitized to CAMP factor, which then effects hemolysis Hemolysis most pronounced in the zone between the colonies of the two bacterial species Co-hemolytic phenomenon- presumptive identification of Group B Streptococci (S. agalactiae) CAMP test First described by Christie, Atkins, and Munch –Petersen in 1944 The protein was named CAMP factor for the initials of the authors of the article that first described the phenomenon Types: Standard CAMP test Rapid CAMP test (spot test ) Standard camp test are time consuming and/or expensive compared to the CAMP spot test Principle CAMP test detects
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2011/0206654 A1 Hodin Et Al
    US 2011 0206654A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2011/0206654 A1 Hodin et al. (43) Pub. Date: Aug. 25, 2011 (54) METHODS OF MODULATING Related U.S. Application Data GASTRONTESTINAL TRACTFLORA LEVELS WITH ALKALINE PHOSPHATASE (60) Provisional application No. 61/093,129, filed on Aug. 29, 2008. (75) Inventors: Richard A. Hodin, Newton, MA (US); Madhu S. Malo, Burlington, Publication Classification MA (US) (51) Int. Cl. (73) Assignee: THE GENERAL, HOSPITAL A638/46 (2006.01) CORPORATION, Boston, MA CI2N 9/16 (2006.01) (US) A6IPI/00 (2006.01) (21) Appl. No.: 13/060,863 (52) U.S. Cl. ........................................ 424/94.6; 435/196 (22) PCT Fled: Aug. 27, 2009 (57) ABSTRACT (86) PCT NO.: PCT/USO9/55216 This invention relates generally to a therapeutic use of alka S371 (c)(1), line phosphatase to modulate gastrointestinal tract flora levels (2), (4) Date: May 5, 2011 in Subject. C 7 e 4 ---. W. Mouse Stoo B Mac Brucella MacConkey Agar Plates Media Aerobic Condition) B D WT AP-KO n . 1 ^: O Š AP-KO Mouse Stool Brucella MacConkey Agar Plates Media (Anaerobic Condition) Patent Application Publication Aug. 25, 2011 Sheet 1 of 7 US 2011/0206654 A1 F.G. 1 W &ws s IAP-KOS ls S 4 S.Š 3 WT Mouse Stoo LB BH Mac Brucella MacConkey Agar Plates Media (Aerobic Condition) D 12 SS 9 : AP-KO Mouse Stool Brucella MacConkey Agar Plates Media (Anaerobic Condition) Patent Application Publication Aug. 25, 2011 Sheet 2 of 7 US 2011/0206654 A1 FIG 2 $2$3$?2 8?duesdødsweeg38),jojaquumN A.
    [Show full text]
  • Use of the Diagnostic Bacteriology Laboratory: a Practical Review for the Clinician
    148 Postgrad Med J 2001;77:148–156 REVIEWS Postgrad Med J: first published as 10.1136/pmj.77.905.148 on 1 March 2001. Downloaded from Use of the diagnostic bacteriology laboratory: a practical review for the clinician W J Steinbach, A K Shetty Lucile Salter Packard Children’s Hospital at EVective utilisation and understanding of the Stanford, Stanford Box 1: Gram stain technique University School of clinical bacteriology laboratory can greatly aid Medicine, 725 Welch in the diagnosis of infectious diseases. Al- (1) Air dry specimen and fix with Road, Palo Alto, though described more than a century ago, the methanol or heat. California, USA 94304, Gram stain remains the most frequently used (2) Add crystal violet stain. USA rapid diagnostic test, and in conjunction with W J Steinbach various biochemical tests is the cornerstone of (3) Rinse with water to wash unbound A K Shetty the clinical laboratory. First described by Dan- dye, add mordant (for example, iodine: 12 potassium iodide). Correspondence to: ish pathologist Christian Gram in 1884 and Dr Steinbach later slightly modified, the Gram stain easily (4) After waiting 30–60 seconds, rinse with [email protected] divides bacteria into two groups, Gram positive water. Submitted 27 March 2000 and Gram negative, on the basis of their cell (5) Add decolorising solvent (ethanol or Accepted 5 June 2000 wall and cell membrane permeability to acetone) to remove unbound dye. Growth on artificial medium Obligate intracellular (6) Counterstain with safranin. Chlamydia Legionella Gram positive bacteria stain blue Coxiella Ehrlichia Rickettsia (retained crystal violet).
    [Show full text]
  • Newborn Colonization and Antibiotic Susceptibility Patterns of Streptococcus Agalactiae at the University of Gondar Referral
    Gizachew et al. BMC Pediatrics (2018) 18:378 https://doi.org/10.1186/s12887-018-1350-1 RESEARCH ARTICLE Open Access Newborn colonization and antibiotic susceptibility patterns of Streptococcus agalactiae at the University of Gondar Referral Hospital, Northwest Ethiopia Mucheye Gizachew1*, Moges Tiruneh1, Feleke Moges1, Mulat Adefris2, Zemene Tigabu3 and Belay Tessema1 Abstract Background: Group B Streptococcus (GBS) that asymptomatically colonizing the recto-vaginal area of women is the most important cause of neonatal colonization. There is paucity of evidence about newborn colonization with GBS in Ethiopia. Thus, this study was aimed to determine the prevalence of newborn colonization with GBS, antibiotic susceptibility patterns of the isolates and associated risk factors at the University of Gondar Referral Hospital in Northwest Ethiopia Methods: A prospective cross sectional study was conducted from December 2016 to November 2017. A total of 1,155 swabs from nasal, ear and umbilical areas of the newborns were collected from the 385 newborns. Identifications of the isolates and antibiotic susceptibility testing were done by using conventional methods. Results: Sixty two (16.1%, 95% CI: 12.2% - 20%) of the newborns were colonized by GBS. Seven percent of the total specimens were positive for GBS. The antibiotics susceptibility rates of GBS (average of the three body sites tested) were 95.1%, 89.6%, 88.9%, 85.7%, 85.3%, 81.3%, 76.9%, 76.1%, 73.8%, and 34.4% to ampicillin, penicillin, ciprofloxacin, chloramphenicol, vancomycin, azitromycin, erythromycin, clindamycin, ceftriaxone, and tetracycline, respectively. A multilogistic regression analyses were shown that the newborns that were from mothers whose education status was below tertiary level, and newborns from mothers who were: being employed, being nullipara and multigravida were at risk for colonization with GBS.
    [Show full text]
  • APPENDIX a Media and Reagents
    APPENDIX A Media and Reagents Pauline K. w. Yu, M.S. The use of appropriate and dependable media is integral to the isolation and identification of microorganisms. Unfortunately, comparative data docu­ menting the relative efficacy or value of media designed for similar purposes are often lacking. Moreover, one cannot presume identity in composition of a given generic product which is manufactured by several companies because each may supplement the generic products with components, often of a proprietary nature and not specified in the product's labeling. Finally, the actual production of similar products may vary among manufacturers to a sufficient extent to affect their performance. For all of these reasons, therefore, product selection for the laboratory should not be strictly based on cost considerations and should certainly not be based on promotional materials. Evaluations that have been published in the scientific literature should be consulted when available. Alternatively, the prospective buyer should consult a recognized authority in the field. It is seldom necessary for the laboratory to prepare media using basic components since these are usually available combined in dehydrated form from commercial sources; however, knowledge of a medium's basic compo­ nents is helpful in understanding how the medium works and what might be wrong when it does not work. Hence, the components have been listed for each medium included in this chapter. All dehydrated media must be prepared exactly according to the manu­ facturers' directions. Any deviation from these directions may adversely affect or significantly alter a medium's performance. Containers of media should be dated on receipt and when opened, and the media should never be used beyond expiration dates specified by the manufacturers or recom­ mended by quality control programs.
    [Show full text]
  • TRYPTIC SOY AGAR - for in Vitro Use Only
    TRYPTIC SOY AGAR - For in vitro use only - Plated Media Tubed Media PT80 –Tryptic Soy Agar (TSA) TT80 – TSA Slant PT81 – TSA (SXT) TT80-18 – TSA Pour Plate [18-mL] PT89 – TSA w Yeast Extract TB75 – TSA Blood Slant PB75 – TSA w 5% Sheep Blood PB81 – TSA w 7% Sheep Blood PB69 – TSA w 5% Horse Blood PB80 – TSA w 7% Horse Blood Tryptic Soy Agar (TSA) is a general purpose The CAMP test can also be used to help identify plating medium used for the isolation, cultivation, pathogenic species of Listeria . and maintenance of a variety of fastidious and non- TSA with horse blood is used to isolate more fastidious microorganisms. fastidious organisms. Horse blood contains both X Leavitt et al. demonstrated the versatility of and V factor, which are essential growth factors for TSA by cultivating both aerobic and anaerobic some organisms such as Haemophilus species. microbes using TSA. TSA is recognized and Sheep and human blood are not suitable since they recommended by numerous agencies around the contain specific enzymes that inactivate V Factor. world. Our standard formulation is prepared Although, some laboratories prefer a plated according to the United States Pharmacopeia medium with a higher blood content (7-10%) or (USP) and recommended for various different with horse blood, these mediums should not be applications put forth by the Association of used for determination of hemolytic reactions or Official Analytical Chemists (AOAC), the for the CAMP test. The increased blood content International Dairy Federation (IDF), the United can make hemolytic reactions less distinct and States Department of Agriculture (USDA), and the more difficult to read while defibrinated horse American Public Health Association (APHA).
    [Show full text]
  • Mucosal Prevalence and Interactions with the Epithelium Indicate Commensalism of Sutterella Spp
    fmicb-07-01706 October 24, 2016 Time: 15:3 # 1 View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Helsingin yliopiston digitaalinen arkisto ORIGINAL RESEARCH published: 26 October 2016 doi: 10.3389/fmicb.2016.01706 Mucosal Prevalence and Interactions with the Epithelium Indicate Commensalism of Sutterella spp. Kaisa Hiippala1*, Veera Kainulainen2, Marko Kalliomäki3, Perttu Arkkila4 and Reetta Satokari1 1 Immunobiology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland, 2 Pharmacology, Faculty of Medicine, University of Helsinki, Helsinki, Finland, 3 Department of Pediatrics, Turku University Central Hospital and Functional Foods Forum, University of Turku, Turku, Finland, 4 Department of Gastroenterology, Helsinki University Central Hospital, Helsinki, Finland Sutterella species have been frequently associated with human diseases, such as autism, Down syndrome, and inflammatory bowel disease (IBD), but the impact of these bacteria on health still remains unclear. Especially the interactions of Sutterella spp. with the host are largely unknown, despite of the species being highly prevalent. Edited by: M. P. Francino, In this study, we addressed the interaction of three known species of Sutterella with FISABIO-Generalitat Valenciana, the intestinal epithelium and examined their adhesion properties, the effect on intestinal Spain barrier function and the pro-inflammatory capacity in vitro. We also studied the relative Reviewed by: abundance and prevalence of the genus Sutterella and Sutterella wadsworthensis Christian U. Riedel, University of Ulm, Germany in intestinal biopsies of healthy individuals and patients with celiac disease (CeD) or Suzanne L. Ishaq, IBD. Our results show that Sutterella spp. are abundant in the duodenum of healthy Montana State University, USA adults with a decreasing gradient toward the colon.
    [Show full text]
  • Streptococci
    STREPTOCOCCI Streptococci are Gram-positive, nonmotile, nonsporeforming, catalase-negative cocci that occur in pairs or chains. Older cultures may lose their Gram-positive character. Most streptococci are facultative anaerobes, and some are obligate (strict) anaerobes. Most require enriched media (blood agar). Streptococci are subdivided into groups by antibodies that recognize surface antigens (Fig. 11). These groups may include one or more species. Serologic grouping is based on antigenic differences in cell wall carbohydrates (groups A to V), in cell wall pili-associated protein, and in the polysaccharide capsule in group B streptococci. Rebecca Lancefield developed the serologic classification scheme in 1933. β-hemolytic strains possess group-specific cell wall antigens, most of which are carbohydrates. These antigens can be detected by immunologic assays and have been useful for the rapid identification of some important streptococcal pathogens. The most important groupable streptococci are A, B and D. Among the groupable streptococci, infectious disease (particularly pharyngitis) is caused by group A. Group A streptococci have a hyaluronic acid capsule. Streptococcus pneumoniae (a major cause of human pneumonia) and Streptococcus mutans and other so-called viridans streptococci (among the causes of dental caries) do not possess group antigen. Streptococcus pneumoniae has a polysaccharide capsule that acts as a virulence factor for the organism; more than 90 different serotypes are known, and these types differ in virulence. Fig. 1 Streptococci - clasiffication. Group A streptococci causes: Strep throat - a sore, red throat, sometimes with white spots on the tonsils Scarlet fever - an illness that follows strep throat. It causes a red rash on the body.
    [Show full text]
  • The Design and Application of a Molecular Profiling Strategy to Identify Polymicrobial Acute Sepsis Infections
    University of Calgary PRISM: University of Calgary's Digital Repository Graduate Studies The Vault: Electronic Theses and Dissertations 2015-08-14 The Design and Application of a Molecular Profiling Strategy to Identify Polymicrobial Acute Sepsis Infections Faria Crowder, Monica Faria Crowder, M. (2015). The Design and Application of a Molecular Profiling Strategy to Identify Polymicrobial Acute Sepsis Infections (Unpublished doctoral thesis). University of Calgary, Calgary, AB. doi:10.11575/PRISM/28047 http://hdl.handle.net/11023/2388 doctoral thesis University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission. Downloaded from PRISM: https://prism.ucalgary.ca UNIVERSITY OF CALGARY The Design and Application of a Molecular Profiling Strategy to Identify Polymicrobial Acute Sepsis Infections by Monica Martins Pereira Faria-Crowder A THESIS SUBMITTED TO THE FACULTY OF GRADUATE STUDIES IN PARTIAL FULFILMENT OF THE REQUIREMENTS FOR THE DEGREE OF DOCTOR OF PHILOSOPY GRADUATE PROGRAM IN MICROBIOLOGY, IMMUNOLOGY, AND INFECTIOUS DISEASES CALGARY, ALBERTA AUGUST 2015 © Monica Martins Pereira Faria-Crowder 2015 Abstract Sepsis is a term used to describe an array of clinical presentations ranging from mild body dysfunction to multiple organ failure. These clinical signs result from a systemic inflammatory response to microbes or microbial products present in sterile sites such as blood. Current clinical diagnostics rely on culture techniques to identify systemic infections.
    [Show full text]
  • BD Industry Catalog
    PRODUCT CATALOG INDUSTRIAL MICROBIOLOGY BD Diagnostics Diagnostic Systems Table of Contents Table of Contents 1. Dehydrated Culture Media and Ingredients 5. Stains & Reagents 1.1 Dehydrated Culture Media and Ingredients .................................................................3 5.1 Gram Stains (Kits) ......................................................................................................75 1.1.1 Dehydrated Culture Media ......................................................................................... 3 5.2 Stains and Indicators ..................................................................................................75 5 1.1.2 Additives ...................................................................................................................31 5.3. Reagents and Enzymes ..............................................................................................75 1.2 Media and Ingredients ...............................................................................................34 1 6. Identification and Quality Control Products 1.2.1 Enrichments and Enzymes .........................................................................................34 6.1 BBL™ Crystal™ Identification Systems ..........................................................................79 1.2.2 Meat Peptones and Media ........................................................................................35 6.2 BBL™ Dryslide™ ..........................................................................................................80
    [Show full text]
  • Perinatal Group B Streptococcal Disease
    Objectives Describe the epidemiology of Group B Update: Perinatal Group B Streptococcus, including incidence and Streptococcal Disease risk factors. Discuss the latest treatment & Michele B. Zitzmann, M.H.S., MT(ASCP) prevention guidelines for perinatal LSUHSC Dept. of Clinical Laboratory Sciences Group B streptococcal disease. New Orleans CLPC Spring, 2017 Group B Streptococcus (GBS) Group B Streptococcus (GBS) Leading bacterial infection associated with Currently: Remains the leading illness and death among newborns in the infectious cause of morbidity & mortality U.S. among newborns in the U.S. • Prior to active prevention activities (1996): – CDC estimates 1,200 cases of GBS –8,000 – 12,000 cases of GBS sepsis & sepsis & meningitis in newborns each year meningitis in newborns each year (U.S.) (U.S.) –Approximately 2,000 deaths – Approximately 70% of cases are among –Direct medical costs: $300 million/year babies born at term (>37 weeks gestation) Group B Streptococcus Gram Stain Streptococcus agalactiae Gram positive cocci – Short chains in clinical specimens – Longer chains in culture Blood Agar plate – Gray-white mucoid colonies – Small zone of beta hemolysis 1 S. agalactiae: Blood Agar Plate Beta-Hemolysis Streptococcus agalactiae CAMP test Laboratory Tests: Used to presumptively identify group B – Catalase: Negative streptococci – 6.5% NaCl: No growth Named after the individuals who discovered the reaction – CAMP test: Positive –Christie, Atkins, & Munch-Petersen – Bile Esculin: Negative Staphylococcus aureus is inoculated
    [Show full text]